Cargando…
IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
Genetic polymorphisms in IFNL4 have been shown to predict responses to IFN-α-based therapy in hepatitis C virus (HCV)-infected patients. The IFNL4-ΔG genotype, which encodes functional IFN-λ4 protein, is associated with a poor treatment response. In the present study, we investigated the induction a...
Autores principales: | Sung, Pil Soo, Hong, Seon-Hui, Chung, Jae-Hee, Kim, Sojeong, Park, Su-Hyung, Kim, Ho Min, Yoon, Seung Kew, Shin, Eui-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476576/ https://www.ncbi.nlm.nih.gov/pubmed/28630501 http://dx.doi.org/10.1038/s41598-017-04186-7 |
Ejemplares similares
-
Contribution of increased ISG15, ISGylation and deregulated Type I IFN signaling in Usp18 mutant mice during the course of bacterial infections
por: Dauphinee, Shauna M., et al.
Publicado: (2014) -
Structural basis of the specificity of USP18 toward ISG15
por: Basters, Anja, et al.
Publicado: (2017) -
Zinc is a potent and specific inhibitor of IFN-λ3 signalling
por: Read, Scott A., et al.
Publicado: (2017) -
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
por: Davidson, Sophia, et al.
Publicado: (2016) -
The ISG15-specific protease USP18 regulates stability of PTEN
por: Mustachio, Lisa Maria, et al.
Publicado: (2016)